Clinical Trials Browser

Prostatic Neoplasms

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell

Muscle Invasive Bladder Cancer (MIBC)

Metastatic Castration-resistant Prostate Cancer

Prostatic Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

Prostatic Neoplasms

Urothelial Bladder Carcinoma

Carcinoma, Renal Cell

Neoplasms, Prostatic Neoplasms

Urinary Bladder Neoplasms, Kidney Neoplasms, Neoplasms, Prostatic Neoplasms, Stress Disorders, Post-Traumatic, Colorectal Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Prostate Adenocarcinoma

Carcinoma, Renal Cell

Prostatic Neoplasms

Urinary Bladder Neoplasms

Prostatic Neoplasms

Carcinoma, Renal Cell, Neoplasms

Prostatic Neoplasms

Urinary Bladder Neoplasms, Kidney Neoplasms, Neoplasms, Ovarian Neoplasms

Prostatic Neoplasms

Urinary Bladder Neoplasms

Carcinoma, Renal Cell, Kidney Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Carcinoma, Renal Cell

Carcinoma, Transitional Cell

Prostatic Neoplasms

Muscle Hypotonia, Prostatic Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Adenocarcinoma, Prostatic Neoplasms, Multiple Endocrine Neoplasia Type 1, Hot Flashes

Prostatic Neoplasms

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

Prostatic Neoplasms

Prostatic Neoplasms

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Melanoma, Ureteral Neoplasms, Urethral Neoplasms

Carcinoma, Renal Cell

Prostatic Neoplasms

Prostatic Neoplasms

Prostatic Neoplasms

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

Carcinoma, Renal Cell

Urinary Bladder Neoplasms, Colorectal Neoplasms

Prostatic Neoplasms

Urinary Bladder Neoplasms, Lung Neoplasms, Urologic Neoplasms

Infiltrating Bladder Urothelial Carcinoma

Clinical Trials

A Study of Tarlatamab for People With Prostate Cancer

Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC

Probiotics Combined With Targeted Therapy Plus Immunotherapy in Bladder-Preserving Setting for Patients With MIBC

Phase 2a Study of High-Dose Testosterone Followed by Radioligand Therapy in mCRPC

ANDARP

Apalutamide, Abiraterone Acetate, and Prednisone in Treating Participants With Metastatic Castration Resistant Prostate Cancer

A Study to Evaluate Hypofractionated Proton Therapy or IMRT for Recurrent, Oligometastatic Prostate Cancer

Sitravatinib and Nivolumab for the Treatment of Metastatic or Advanced Clear Cell Renal Cell Cancer

Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic Prostate Cancer

PeRioperative Immunotherapy Combined With Sacituzumab Govitecan in Muscle Invasive blAdder Cancer

EXACT

CKNO-PRO

NeuroPrevPTSD

Abiraterone and Prednisone or Darolutamide for the Treatment of Advanced Prostate Cancer

Re-treatment With 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer, RE-LuPSMA Trial

RATIONAL

A Randomized Phase 2 Trial of Nivolumab, Relatlimab Plus Ipilimumab vs. Nivolumab Plus Ipilimumab in First-line Advanced Renal Cell Carcinoma (RCC)

Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial

TRIFECTA

A Study of BMS986365 in Combination With Degarelix in People With Prostate Cancer

An Open-label, Randomized Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of the Combination Therapy of SLC-3010 and Axitinib Compared to Axitinib Monotherapy as a Second-line Treatment for Locally Advanced or Metastatic Clear Cell Renal Cell Carcinoma

Golimumab and Apalutamide for the Treatment of Castration-Resistant Prostate Cancer, TRAMP Study

Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery

Intensive Cholesterol-Lowering and CD8+ T Cells in Prostate Cancer

Intravesical Gemcitabine and Docetaxel for Low Grade Intermediate Risk Bladder Cancer

CAIX PET/CT

TeLuNa

Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT)

PRELUDE

AVESEC

Brachytherapy for Prostatic Carcinoma Patients

The Effect of Deep Versus Moderate Muscle Relaxants in Men During and After Robotic Surgery for Prostate Cancer

Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer

Comeback From Long coursE Androgen Deprivation Therapy (ADT) With RElugolix and Darolutamide (CLEARED)

Fezo-ADT

Transrectal Tumour Oxygen - US Army

Bristol Bladder Trial

Abiraterone Acetate, Prednisone, and Apalutamide With or Without Ipilimumab or Cabazitaxel and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

Focal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy (ADT), Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON)

Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma

Study of Adaptive Immunotherapy With VEGFR-TKI in Patients With Advanced RCC

Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT

Study of Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients Receiving Androgen Deprivation Therapy

TOPP

Lenvatinib With Everolimus Versus Cabozantinib for Second-Line or Third-Line Treatment of Metastatic Renal Cell Cancer

PLUTO

Telehealth Intervention for Ostomy Self-Management

SHARP

Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant Cancers

Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations